How integrated insights supported a biologic launch strategy across multiple indications
Our client is launching a new biologic in immunology across several indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and reimbursement as well the pricing opportunity. They wanted to use the insights to develop the optimal launch strategy across 12 markets and across indications, and also support the local market access teams by conducting a mock negotiation with payers.
Conducting research for publication
Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their value to patients, healthcare and society.
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Novel cancer therapies are offering patients new treatments and better outcomes worldwide. And recent changes in healthcare policies across APAC, such as China’s fast tracking approval of therapies for severe and rare diseases, have reignited interest in the APAC region as a strong market for oncology.
Are dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.
Therapy Watch Associate Director Raquel Nuñez, discusses continuing improvements in HIV therapies and the evolution of single-tablet regimens (STRs) over time.
Research Partnership welcomes four project management apprentices
We are delighted to announce that we have recruited 4 new Project Management Apprentices at our London office this month, in a collaboration with West London College.